793 related articles for article (PubMed ID: 16204303)
21. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
23. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
[TBL] [Abstract][Full Text] [Related]
24. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine experience in nephrotic syndrome.
Phadke K; Ballal S; Maiya V
Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
[TBL] [Abstract][Full Text] [Related]
26. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
27. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
[TBL] [Abstract][Full Text] [Related]
28. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
29. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
[TBL] [Abstract][Full Text] [Related]
32. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
[TBL] [Abstract][Full Text] [Related]
33. Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome.
Jeong HJ; Kim JH; Kim PK; Choi IJ
Clin Nephrol; 2001 Apr; 55(4):289-96. PubMed ID: 11334314
[TBL] [Abstract][Full Text] [Related]
34. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
Ariceta Iraola G; Rodríguez Soriano J; Vallo Boado A; Quintela Pérez MJ; Oliveros Pérez R
An Esp Pediatr; 1997 Sep; 47(3):273-8. PubMed ID: 9499280
[TBL] [Abstract][Full Text] [Related]
36. [Remission of nephrotic syndrome in children treated with corticosteroids and other immunosuppressive therapy].
Zecević-Cemerlić E; Milicić D; Misanović V
Med Arh; 1999; 53(3 Suppl 2):35-8. PubMed ID: 10758759
[TBL] [Abstract][Full Text] [Related]
37. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study.
Sheashaa H; Mahmoud I; El-Basuony F; El-Husseini A; Hassan N; El-Baz M; Ahmed NS; Sobh M
Int Urol Nephrol; 2007; 39(3):923-8. PubMed ID: 17447154
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P; Jesdapatarakul S
J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
[TBL] [Abstract][Full Text] [Related]
39. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
40. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
Shin JI; Park JM; Shin YH; Kim JH; Lee JS; Jeong HJ
Scand J Rheumatol; 2005; 34(5):392-5. PubMed ID: 16234188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
